Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shanxi Qianyecao Biotech QYC

Shanxi Qianyecao Biotech QYC
Tirzepatide

Finnrick tested 2 samples of Tirzepatide (GLP-1 and GIP antagonist) from Shanxi Qianyecao Biotech QYC between 11 Jun 2025 and 5 Aug 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
B
GOOD
Tentative Rating
Shanxi Qianyecao Biotech QYC
Tirzepatide
Tested 2 Samples
Last test 5 Aug 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Test My Sample

Other Tirzepatide tests from top-rated vendors:

Polaris Peptides
A
Reta-Peptide
A
Skye Peptides
A

All Tirzepatide tests from Shanxi Qianyecao Biotech QYC

Samples are tested in commercial labs

Tests Count

2

Scores

AVG6.4MIN5.5MAX7.2

Last

5 Aug 2025

First

11 Jun 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
5 Aug 2025View7.210mg9.330mg-6.7%99.81%(no batch ID)No Label / Silver Crimp / Clear Green CapLab EPublic
11 Jun 2025View5.530mg26.300mg-12.3%99.72%(no batch ID)No Label / Silver Crimp / Black CapLab EPublic